Sign in to follow
Search Results

0 results for 'U.S. Patent and Trademark Office'

You can use to get even better search results
The Research Found. for the State of N.Y. v. Inpria Corp.
Publication Date: 2024-04-11
Practice Area: Civil Procedure | Intellectual Property
Industry: Education
Court: U.S. District Court for the Northern District of New York, U.S. - NDNY
Judge: Chief Judge Brenda K. Sannes
Attorneys:
For plaintiff: For Plaintiff: Andrew R. Safranko, Lamarche Safranko Law PLLC, Cohoes, NY. John E. Schiltz, Susman Godfrey L.L.P., Seattle, WA. Justin A. Nelson, Susman Godfrey L.L.P., Houston, TX. Argie L. Mina, Susman Godfrey L.L.P, Los Angeles, CA. Samir Doshi, Susman Godfrey L.L.P., New York, NY.
For defendant: For Defendants: Joshua Bennett, Eric W. Dittmann, Isaac S. Ashkenazi, Paul Hastings LLP, New York, NY. Naveen Modi, Phillip W. Citroen, Paul Hastings, LLP, Washington, DC. James J. O'Shea, John G. Powers, Mary L. D'Agostino, Hancock Estabrook, LLP, Syracuse, NY.
Case number: 1:24-CV-120

Denial of Injunctive Relief Explained in Suit Over Use of SUNY RF's Intellectual Property

April 05, 2024 | Pro Mid Market

Who Got the Work: Heyl Royster Partner Tapped to Defend Blackstone Medical Services in Consumer Class Action Suit

Heyl, Royster, Voelker & Allen partner John P. Heil Jr. has entered an appearance for Blackstone Medical Services in a pending consumer class action.
2 minute read
April 05, 2024 | Legaltech News

Da Vinci Partners Sues Kili Technology, Claiming Gen AI Tool 'davinci' Infringes Trademark

Swiss patent law firm Da Vinci Partners sued Kili Technology for trademark infringement and unfair competition over the naming of its generative AI-powered patent drafting tool davinci, arguing the lines between "goods" and "services" have blurred. This case was first surfaced by Law.com Radar.
3 minute read
April 05, 2024 | National Law Journal

Da Vinci Law Firm Claims Kili Technology's Gen AI Tool 'davinci' Infringes Trademark

Swiss patent firm Da Vinci Partners sued Kili Technology over the naming of its patent drafting tool davinci, arguing the lines between "goods" and "services" have blurred.
3 minute read
March 27, 2024 | The Legal Intelligencer

Changing Times: Finding a Trademark Offensive Now Off the Table

While the USPTO is no longer allowed to be offended by these trademarks, it's not entirely clear how popular these marks and their associated goods and services might be in the marketplace.
6 minute read
Law Journal Press | Digital Book America Invents Act (AIA) Handbook: A Guide to the Patent Law Reform of 2011, The, 2015 Edition Authors: Mary Anthony Merchant View this Book

View more book results for the query "U.S. Patent and Trademark Office"

March 27, 2024 | New Jersey Law Journal

Can AI Invent? USPTO Provides Guidance on AI-Impacted Inventorship

"Where is the line between AI rising to the role of inventor and mere AI assistance for human inventors?" write Jeffrey Weinick and Drew Berweger of CSG Law's patent group.
6 minute read
March 26, 2024 | Daily Business Review

From Deep Fakes to Discrimination: Lawyers Weigh in on A.I. Landmines

"I'm a huge proponent of AI, but it must be used with guardrails, and too many are rushing to use it," said attorney Francisco Ramos Jr. of Clarke Silverglate.
5 minute read
March 26, 2024 | New York Law Journal

Patent Office Issues New Guidance on the Law of Obviousness

The United States Patent and Trademark Office recently published new guidance explaining the requirements for patent examiners to reject patent claims for obviousness in view of what was already known in the prior art.
8 minute read
Regeneron Pharmaceuticals Inc. v. Novartis Pharma AG
Publication Date: 2024-03-26
Practice Area: Antitrust | Business Torts
Industry: Pharmaceuticals
Court: U.S. Court of Appeals for the Second Circuit
Judge: Circuit Judge Barrington D. Parker
Attorneys:
For plaintiff: For Plaintiff-Appellant: Joshua Halpern, Elizabeth S. Weiswasser, Eric S. Hochstadt, & Anish R. Desai, on the brief, Adam Banks, Weil, Gotshal & Manges LLP, New York, NY & Washington, D.C.
For defendant: For Defendants-Appellees Novartis Pharma AG, Novartis Technology LLC, and Novartis Pharmaceuticals Corp.: Ian Simmons, Lisa Pensabene, Stephen J. McIntyre, & Melissa C. Cassel, on the brief, William Jay, O'Melveny & Myers LLP, Washington, D.C., New York, NY, Los Angeles, CA & San Francisco, CA. Benjamin T. Horton & Julianne M. Hartzell, on the brief, Marshall Gerstein & Borun LLP, Chicago, IL, for Defendant-Appellee Vetter Pharma International GmbH. Anisha S. Dasgupta & Joel Marcus, on the brief, Matthew M. Hoffman, Federal Trade Commission, Washington, D.C., and Jonathan S. Kanter, Daniel E. Haar, Nickolai G. Levin, & Andrew N. DeLaney, on the brief, United States Department of Justice, Antitrust Division, Washington, D.C., Amici Curiae in Support of Neither Party.
Case number: 22-0427-cv

Anti-VEGF Medications in Vials, Pre-Filled Syringes Compete in Different Product Markets

March 22, 2024 | New York Law Journal

'In re Cellect': How Patent Owners Can Protect Themselves From Obviousness-Type Double Patenting Invalidity Determinations

The recent case of 'In re Cellect' serves as a warning to patent owners who rely too heavily on the USPTO to completely and accurately examine their patent applications. This article presents patent owners with several options to consider to avoid a fate similar to Cellect.
7 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources

    • Corporate Transparency Act Resource Kit

      Brought to you by Wolters Kluwer

      Download Now

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now

    • Law Firm Operational Considerations for the Corporate Transparency Act

      Brought to you by Wolters Kluwer

      Download Now

    • The Ultimate Guide to Remote Legal Work

      Brought to you by Filevine

      Download Now